Ranolazine Bests Old School Antianginal Medications

This article originally appeared here.
Share this content:
Ranolazine Bests Old School Antianginal Medications
Ranolazine Bests Old School Antianginal Medications

MONDAY, Nov. 2, 2015 (HealthDay News) -- Newer antianginal (AA) medications such as ranolazine show substantial outcome improvements in chronic stable angina pectoris (CSA) compared to traditional medications, according to a study published in the Nov. 1 issue of The American Journal of Cardiology.

Robert L. Page II, Pharm.D., M.S.P.H., from the University of Colorado Skaggs School of Pharmacy in Aurora, and colleagues analyzed a commercial claims database (2008 to 2012) to identify patients with CSA receiving a β-blocker (BB), calcium channel blocker (CCB), long-acting nitrate (LAN), or ranolazine (2,002 patients in each matched group). Patients were followed for 12 months after a change in AA therapy. A subset of 3,724 patients with diabetes were identified (BB, 933 patients; CCB, 940; LAN, 937; and ranolazine, 914).

The researchers found that in the overall cohort, traditional AA medication exhibited greater odds for revascularization and higher rates in all-cause outpatient visits, emergency room visits, inpatient length of stay, and cardiovascular-related emergency room visits, compared to ranolazine. In the diabetes mellitus cohort, ranolazine exhibited similar benefits over traditional AA medication.

"In conclusion, ranolazine use in patients with inadequately controlled chronic angina is associated with less revascularization and all-cause and cardiovascular-related health care utilization compared to traditional AA medication," the authors write.

Several authors disclosed financial ties to Gilead Sciences, which funded the study.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Hormonal Contraception May Raise Depression Risk

Hormonal Contraception May Raise Depression Risk

Study also ties hormonal patches, IUDs to greater antidepressant use, especially in teens

Dose-Dependent Link Between Cannabis Use, Psychosis Relapse

Dose-Dependent Link Between Cannabis Use, Psychosis Relapse

But researchers note effect is small, and the research isn't definitive

Systolic Blood Pressure Variability Linked to Mortality, Morbidity

Systolic Blood Pressure Variability Linked to Mortality, Morbidity

Increased SBP variability tied to mortality, coronary heart disease, stroke, end-stage renal disease

is free, fast, and customized just for you!

Already a member?

Sign In Now »